Risk factors for recurrent biliary obstruction following placement of self-expandable metallic stents in patients with malignant perihilar biliary stricture

Background and study aim: Self-expandable metallic stents (SEMSs) are used for palliation in patients with malignant perihilar biliary strictures. However, recurrent biliary obstruction occasionally causes cholangitis and jaundice. This study aimed to identify risk factors for recurrent biliary obstruction in such patients.

Methods: Data from consecutive patients with malignant perihilar biliary strictures treated with endoscopic placement of SEMSs between 2007 and 2014 in Tohoku University Hospital were retrospectively reviewed. Risk factors for recurrent biliary obstruction were calculated using the Cox proportional hazards models (with hazard ratios [HRs] and 95 % confidence interval [95 %CIs]), and SEMS patency period was examined using the Kaplan – Meier method. SEMS patency was defined as the period between SEMS insertion and the development of recurrent biliary obstruction.

Results: 104 patients were included. Median survival time was 281 days; and 85 patients died during a median follow-up period of 320 days. Recurrent biliary obstruction occurred in 35 patients. Median SEMS patency period was 549 days. Multivariable analyses showed that: compared with bile duct carcinoma, gallbladder carcinoma was associated with shorter SEMS patency (HR 8.18, 95 %CI 2.41 – 26.83); patency of left-sided SEMS was inferior to that of bilateral (HR 0.5, 95 %CI 0.32 – 0.93) and right-sided SEMS (HR 0.1, 95 %CI 0.02 – 0.65). Cholangitis before SEMS placement increased the risk of recurrent biliary obstruction (HR 11.44; 95 %CI 4.48 – 32.35) and reduced the SEMS patency period (746 vs. 210 days).

Conclusion: Gallbladder carcinoma, left-sided stent placement, and cholangitis before SEMS placement are risk factors for recurrent biliary obstruction after SEMS placement.

• References

• 1 Nakeeb A, Pitt HA, Sohn TA et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-473
• 2 Cheng JL, Bruno MJ, Bergman JJ et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 2002; 56: 33-39
• 3 Mukai T, Yasuda I, Nakashima M et al. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J Hepatobiliary Pancreat Sci 2013; 20: 214-222
• 4 Raju RP, Jaganmohan SR, Ross WA et al. Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis Sci 2011; 56: 1557-1564
• 5 De Palma GD, Pezzullo A, Rega M et al. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc 2003; 58: 50-53
• 6 Chen JH, Sun CK, Liao CS et al. Self-expandable metallic stents for malignant biliary obstruction: efficacy on proximal and distal tumors. World J Gastroenterol 2006; 12: 119-122
• 7 Kawamoto H, Tsutsumi K, Harada R et al. Endoscopic deployment of multiple JOSTENT SelfX is effective and safe in treatment of malignant hilar biliary strictures. Clin Gastroenterol Hepatol 2008; 6: 401-408
• 8 Kogure H, Isayama H, Nakai Y et al. Newly designed large cell Niti-S stent for malignant hilar biliary obstruction: a pilot study. Surg Endosc 2011; 25: 463-467
• 9 Lee TH, Park DH, Lee SS et al. Technical feasibility and revision efficacy of the sequential deployment of endoscopic bilateral side-by-side metal stents for malignant hilar biliary strictures: a multicenter prospective study. Dig Dis Sci 2012; 58: 547-555
• 10 Kim DU, Kang DH, Kim GH et al. Bilateral biliary drainage for malignant hilar obstruction using the 'stent-in-stent' method with a Y-stent: efficacy and complications. Eur J Gastroenterol Hepatol 2013; 25: 99-106
• 11 Liberato MJ, Canena JM. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gasteroenterol 2012; 12: 103
• 12 Isayama H, Tsujino T, Nakai Y et al. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma. World J Gastroenterol 2012; 18: 2364-2370
• 13 Naitoh I, Ohara H, Nakazawa T et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J Gasteroenterol Hepatol 2009; 24: 552-557
• 14 Kawashima H, Itoh A, Ohno E et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications. Ann Surg 2013; 257: 121-127
• 15 Wagner HJ, Knyrim K, Vakil N et al. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 1993; 25: 213-218
• 16 Siddiqui A, Shahid H, Sarkar A et al. Stage of hilar cholangiocarcinoma predicts recurrence of biliary obstruction in patients with metal stents. Clin Gasteroenterol Hepatol 2013; 11: 1169-1173
• 17 Peters RA, Williams SG, Lombard M et al. The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy 1997; 29: 10-16
• 18 Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988; 12: 39-47
• 19 Naito I, Nakazawa T, Ban T et al. 8-mm versus 10-mm diameter self-expandable metallic stent in bilateral endoscopic stent-in-stent deployment for malignant hilar biliary obstruction. J Hepatobiliary Pancreat Sci 2015; 22: 396-401
• 20 Isayama H, Hamada T, Yasuda I et al. TOKYO criteria 2014 for transpapillary biliary stenting. Dig Endosc 2015; 27: 259-264
• 21 Kogure H, Isayama H, Nakai Y et al. High single-session success rate of endoscopic bilateral stent-in-stent placement with modified large cell Niti-S stents for malignant hilar biliary obstruction. Dig Endosc 2014; 26: 93-99
• 22 Rich JT, Neely JG, Paniello RC et al. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg 2010; 143: 331-336
• 23 Miura S, Kanno A, Masamune A et al. Bismuth classification is associated with the requirement for multiple biliary drainage in preoperative patients with malignant perihilar biliary stricture. Surg Endosc 2015; 29: 1862-1870 Epub 2014 Oct 3
• 24 Chahal P, Baron TH. Expandable metal stents for endoscopic bilateral stent-within-stent placement for malignant hilar biliary obstruction. Gastrointest Endosc 2010; 71: 195-199
• 25 Dumonceau JM, Tringali A, Blero D et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 2012; 44: 277-298
• 26 Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 2014; 6: 99-109
• 27 Boutros C, Gary M, Baldwin K et al. Gallbladder cancer: past, present and an uncertain future. Surg Oncol 2012; 21: 183-191
• 28 Lee DK, Kim HS, Kim KS et al. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc 2005; 61: 296-301
• 29 Suk KT, Kim JW, Kim HS et al. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study. Gastrointerest Endosc 2007; 66: 798-803
• 30 Costamagna G, Boskoski I, Familiari P et al. Update in biliary endoscopy. Dig Dis 2011; 29 (Suppl. 01) 3-8
• 31 De Palma GD, Galloro G, Siciliano S et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: Results of a prospective, randomized, and controlled study. Gastrointest Endosc 2001; 53: 547-553
• 32 Vienne A, Hobeika E, Gouya H et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc 2010; 72: 728-735
• 33 Uchida N, Tsutsui K, Ezaki T et al. Estimation of the stent placement above the intact sphincter of Oddi against malignant bile duct obstruction. J Gasteroenterol 2005; 40: 291-296
• 34 Kogure H, Isayama H, Kawakubo K et al. Endoscopic bilateral metallic stenting for malignant hilar obstruction using newly designed stents. J Hepatobiliary Pancreat Sci 2011; 18: 653-657
• 35 Mukai T, Yasuda I, Isayama H et al. Comparison of axial force and cell width of self-expandable metallic stents: which type of stent is better suited for hilar biliary strictures?. J Hepatobiliary Pancreat Sci 2011; 18: 646-652